|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9 Suppl 2
|
|
pubmed:dateCreated |
1993-2-25
|
|
pubmed:abstractText |
The evidence of a beneficial role of antibacterial drugs in Crohn's disease is largely empirical. Data accumulate to show that these drugs may well be used as an adjunctive therapy to oral anti-inflammatory drugs. Circumstantial evidence has also been provided that antibacterial drugs are effective in relieving symptoms related to bacterial overgrowth and when used for specific indications such as perianal lesions.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0392-0623
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
24
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
17-8
|
|
pubmed:dateRevised |
2005-11-16
|
|
pubmed:meshHeading |
pubmed-meshheading:1486195-Anti-Bacterial Agents,
pubmed-meshheading:1486195-Anti-Inflammatory Agents,
pubmed-meshheading:1486195-Antibiotics, Antitubercular,
pubmed-meshheading:1486195-Bacterial Infections,
pubmed-meshheading:1486195-Crohn Disease,
pubmed-meshheading:1486195-Dapsone,
pubmed-meshheading:1486195-Humans,
pubmed-meshheading:1486195-Intestinal Absorption,
pubmed-meshheading:1486195-Metronidazole,
pubmed-meshheading:1486195-Rifamycins
|
|
pubmed:articleTitle |
Antibacterial drugs in Crohn's disease.
|
|
pubmed:affiliation |
Dipartimento di Medicina Sperimentale e Clinica, Università di Reggio Calabria, Catanzaro, Italy.
|
|
pubmed:publicationType |
Journal Article,
Review
|
